The inhibition of glucose utilization is accompanied by a down-regulatory effect of STS on the glutamine transporters Slc1a5 and glutaminase, which catalyze glutamine catabolism and provide cancer cells with bio-synthetic precursors for aminoacids and DNA synthesis [45-47]. Here, SLC1A5 is linked to cancer.